Sera Prognostics (NASDAQ: SERA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Sera Prognostics (NASDAQ: SERA) through any online brokerage.
The latest price target for Sera Prognostics (NASDAQ: SERA) was reported by Oppenheimer on Monday, July 18, 2022. The analyst firm set a price target for 17.00 expecting SERA to rise to within 12 months (a possible 679.82% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Sera Prognostics (NASDAQ: SERA) is $2.18 last updated August 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.